"Parents still ask about this. Indeed, many years ago the FDA approved a prescription form of a PUFA, Vayarin, for the treatment of patients with ADHD. It is no longer available, so I assume it did not work. There may be good reasons for taking a PUFA supplement, but having ADHD is not one of them." -Jon Matthew Farber, MD
Acccording to a commentary on a Cochrane review of the efficacy of ω-3 and ω-6 polyunsaturated fatty acids (PUFAs) in patients with attention deficit hyperactivity disorder (ADHD), only “low-certainty evidence” supports the notion that such supplementation is more effective than placebo for alleviating ADHD symptoms. In addition, “high-certainty evidence” indicates that PUFA supplementation does not improve core ADHD symptoms, according to the commentary authors. These findings suggest that clinicians should not recommend PUFA supplements as a standalone routine treatment for ADHD, according to the commentary authors.
The review on which the commentary was based included data from 37 randomized controlled trials in more than 2,374 children and adolescents with ADHD. Reported outcomes included ADHD symptoms, behavioral problems, quality of life, adverse effects, and loss to follow-up.
Parents still ask about this. Indeed, many years ago the FDA approved a prescription form of a PUFA, Vayarin, for the treatment of patients with ADHD. It is no longer available, so I assume it did not work. There may be good reasons for taking a PUFA supplement, but having ADHD is not one of them.
Reference
Young VM. Are polyunsaturated fatty acids effective for attention-deficit/hyperactivity disorder in children and adolescents? a Cochrane review summary with commentary. Dev Med Child Neurol. 2024;66(5):551-553. doi:10.1111/dmcn.15888
Understanding TMS therapy for major depressive disorder
October 18th 2024Melissa Fickey, MD, explains TMS therapy for major depressive disorder, and highlights key positive data for NeuroStar TMS Therapy, which was presented at the American Academy of Child and Adolescent Psychiatry (AACAP) meeting in Seattle, Washington.
Matthew Davis, MD, FAAP, on current, key pediatric health care themes
October 15th 2024The ongoing challenges of mental health, artificial intelligence, and the addressing of social determinants of health are key themes of pediatric health care are topics of discussion with Matthew Davis, MD, FAAP in this video interview.